Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.

Veronika K JaegerGabriele ValentiniEric HachullaFranco CozziOliver DistlerPaolo AiróLaszlo CzirjákYannick AllanoreElise SiegertEdoardo RosatoMarco Matucci-CerinicCristian CaimmiJörg HenesPatricia E CarreiraVanessa SmithFrancesco Del GaldoChristopher P DentonSusanne UllmanEllen De LangheValeria RiccieriJuan J Alegre-SanchoSimona RednicUlf Müller-LadnerUlrich A Walkernull null

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2018)

The known adverse effect of smoking on bronchial airways and alveoli is also observed in SSc patients; however, robust adverse effects of smoking on the progression of SSc-specific pulmonary or cutaneous manifestations were not observed.

Keyphrases

systemic sclerosis
interstitial lung disease
smoking cessation
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
pulmonary hypertension
cystic fibrosis
peritoneal dialysis
prognostic factors
emergency department
idiopathic pulmonary fibrosis
electronic health record